Company intelligence / Profile preview

Cibus Biotech

San Diego, California, United Statescibusbiotech.com ↗

Ownership: Private
Employees: ~159
Development stage: Other

Overview

Cibus has developed and commercialized several gene-edited crop traits using its proprietary RTDS platform. The company reports successful milestones in developing disease-resistant canola and advancing weed management traits in rice. Its technologies enable rapid trait development—delivering new plant characteristics within customer germplasm in less than 12 months—and are positioned as indistinguishable from conventional breeding outcomes[4].

Therapeutic areas: Other
Modalities: Gene editing technologyNon-transgenic gene editing
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Cibus Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cibus Biotech.

Explore the full profile